Dive Brief: Analysts at Baird Equity Research predict continued strong adoption of insulin pumps and continuous glucose monitoring systems in 2020, backed by up to seven expected major product approvals and launches, simplified devices, increased manufacturing capacity, better insurance reimbursement and evidence of improving patient outcomes. The analysts believe continuous glucose monitor use could reach 80% of the U.S. market over …